Literature DB >> 27281568

The Roles of Type I Interferon in Bacterial Infection.

Gayle M Boxx1, Genhong Cheng2.   

Abstract

Type I interferons (IFNs) are pleiotropic cytokines well recognized for their role in the induction of a potent antiviral gene program essential for host defense against viruses. They also modulate innate and adaptive immune responses. However, the role of type I IFNs in host defense against bacterial infections is enigmatic. Depending on the bacterium, they exert seemingly opposite and capricious functions. In this review, we summarize the effect of type I IFNs on specific bacterial infections and highlight the effector mechanisms regulated by type I IFNs in an attempt to elucidate new avenues to understanding their role.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27281568      PMCID： PMC5847370          DOI： 10.1016/j.chom.2016.05.016

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN： 1931-3128            Impact factor:   21.023


  98 in total

1.  Dissection of a type I interferon pathway in controlling bacterial intracellular infection in mice.

Authors:  Juliane Lippmann; Holger C Müller; Jan Naujoks; Christoph Tabeling; Sunny Shin; Martin Witzenrath; Katharina Hellwig; Carsten J Kirschning; Gregory A Taylor; Winfried Barchet; Stefan Bauer; Norbert Suttorp; Craig R Roy; Bastian Opitz
Journal:  Cell Microbiol       Date:  2011-08-24       Impact factor: 3.715

2.  Type I Interferon Signaling Prevents IL-1β-Driven Lethal Systemic Hyperinflammation during Invasive Bacterial Infection of Soft Tissue.

Authors:  Virginia Castiglia; Alessandra Piersigilli; Florian Ebner; Marton Janos; Oliver Goldmann; Ursula Damböck; Andrea Kröger; Sigfried Weiss; Sylvia Knapp; Amanda M Jamieson; Carsten Kirschning; Ulrich Kalinke; Birgit Strobl; Mathias Müller; Dagmar Stoiber; Stefan Lienenklaus; Pavel Kovarik
Journal:  Cell Host Microbe       Date:  2016-03-09       Impact factor: 21.023

3.  Blockade of chronic type I interferon signaling to control persistent LCMV infection.

Authors:  Elizabeth B Wilson; Douglas H Yamada; Heidi Elsaesser; Jonathan Herskovitz; Jane Deng; Genhong Cheng; Bruce J Aronow; Christopher L Karp; David G Brooks
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

4.  The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses.

Authors:  Vijay A K Rathinam; Zhaozhao Jiang; Stephen N Waggoner; Shruti Sharma; Leah E Cole; Lisa Waggoner; Sivapriya Kailasan Vanaja; Brian G Monks; Sandhya Ganesan; Eicke Latz; Veit Hornung; Stefanie N Vogel; Eva Szomolanyi-Tsuda; Katherine A Fitzgerald
Journal:  Nat Immunol       Date:  2010-03-28       Impact factor: 25.606

5.  TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta.

Authors:  Jonathan C Kagan; Tian Su; Tiffany Horng; Amy Chow; Shizuo Akira; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2008-02-24       Impact factor: 25.606

Review 6.  Regulation of type I interferon responses.

Authors:  Lionel B Ivashkiv; Laura T Donlin
Journal:  Nat Rev Immunol       Date:  2014-01       Impact factor: 53.106

7.  RNase-L deficiency exacerbates experimental colitis and colitis-associated cancer.

Authors:  Tiha M Long; Arindam Chakrabarti; Heather J Ezelle; Sarah E Brennan-Laun; Jean-Pierre Raufman; Irina Polyakova; Robert H Silverman; Bret A Hassel
Journal:  Inflamm Bowel Dis       Date:  2013-05       Impact factor: 5.325

8.  An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.

Authors:  Matthew P R Berry; Christine M Graham; Finlay W McNab; Zhaohui Xu; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Romain Banchereau; Jason Skinner; Robert J Wilkinson; Charles Quinn; Derek Blankenship; Ranju Dhawan; John J Cush; Asuncion Mejias; Octavio Ramilo; Onn M Kon; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Anne O'Garra
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

9.  The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response.

Authors:  Kislay Parvatiyar; Zhiqiang Zhang; Rosane M Teles; Songying Ouyang; Yan Jiang; Shankar S Iyer; Shivam A Zaver; Mirjam Schenk; Shang Zeng; Wenwan Zhong; Zhi-Jie Liu; Robert L Modlin; Yong-jun Liu; Genhong Cheng
Journal:  Nat Immunol       Date:  2012-11-11       Impact factor: 25.606

10.  Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes.

Authors:  Victoria Auerbuch; Dirk G Brockstedt; Nicole Meyer-Morse; Mary O'Riordan; Daniel A Portnoy
Journal:  J Exp Med       Date:  2004-08-09       Impact factor: 14.307
View more
  110 in total

Review 1.  Inflammation and Pneumonia: Why Are Some More Susceptible than Others?

Authors:  Joseph P Mizgerd
Journal:  Clin Chest Med       Date:  2018-12       Impact factor: 2.878

2.  Type I interferon remodels lysosome function and modifies intestinal epithelial defense.

Authors:  Hailong Zhang; Abdelrahim Zoued; Xu Liu; Brandon Sit; Matthew K Waldor
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-10       Impact factor: 11.205

3.  cGAS-STING-TBK1-IRF3/7 induced interferon-β contributes to the clearing of non tuberculous mycobacterial infection in mice.

Authors:  Nanthapon Ruangkiattikul; Andreas Nerlich; Ketema Abdissa; Stefan Lienenklaus; Abdulhadi Suwandi; Nina Janze; Kristin Laarmann; Julia Spanier; Ulrich Kalinke; Siegfried Weiss; Ralph Goethe
Journal:  Virulence       Date:  2017-04-19       Impact factor: 5.882

4.  Mycobacterium tuberculosis Inhibits Autocrine Type I IFN Signaling to Increase Intracellular Survival.

Authors:  Dallas A Banks; Sarah E Ahlbrand; V Keith Hughitt; Swati Shah; Katrin D Mayer-Barber; Stefanie N Vogel; Najib M El-Sayed; Volker Briken
Journal:  J Immunol       Date:  2019-03-04       Impact factor: 5.422

5.  The probacterial effect of type I interferon signaling requires its own negative regulator USP18.

Authors:  Namir Shaabani; Nadine Honke; Nhan Nguyen; Zhe Huang; Kei-Ichiro Arimoto; Daniel Lazar; Taylor K Loe; Karl S Lang; Marco Prinz; Klaus-Peter Knobeloch; Dong-Er Zhang; John R Teijaro
Journal:  Sci Immunol       Date:  2018-09-28

6.  Type I IFN signaling in T regulatory cells modulates chemokine production and myeloid derived suppressor cells trafficking during EAE.

Authors:  Shalini Tanwar; Cihan Oguz; Amina Metidji; Eric Dahlstrom; Kent Barbian; Kishore Kanakabandi; Lydia Sykora; Ethan M Shevach
Journal:  J Autoimmun       Date:  2020-07-22       Impact factor: 7.094

7.  An alternative model for type I interferon induction downstream of human TLR2.

Authors:  Timo Oosenbrug; Michel J van de Graaff; Mariëlle C Haks; Sander van Kasteren; Maaike E Ressing
Journal:  J Biol Chem       Date:  2020-08-12       Impact factor: 5.157

8.  HECTD3 mediates TRAF3 polyubiquitination and type I interferon induction during bacterial infection.

Authors:  Fubing Li; Yang Li; Huichun Liang; Tao Xu; Yanjie Kong; Maobo Huang; Ji Xiao; Xi Chen; Houjun Xia; Yingying Wu; Zhongmei Zhou; Xiaomin Guo; Chunmiao Hu; Chuanyu Yang; Xu Cheng; Ceshi Chen; Xiaopeng Qi
Journal:  J Clin Invest       Date:  2018-07-30       Impact factor: 14.808

Review 9.  Effects of type I interferons in malaria.

Authors:  Ismail Sebina; Ashraful Haque
Journal:  Immunology       Date:  2018-07-05       Impact factor: 7.397

Review 10.  Protective and Pathogenic Effects of Interferon Signaling During Pregnancy.

Authors:  Rebecca L Casazza; Helen M Lazear; Jonathan J Miner
Journal:  Viral Immunol       Date:  2019-09-23       Impact factor: 2.257
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.